What is the active ingredient in Maymetsi?

Sitagliptinum + Metformini hydrochloridum (Metformini hydrochloridum, Sitagliptinum)

What pharmaceutical form is Maymetsi available in?

Maymetsi: Tabletki powlekane 50 mg + 850 mg (doustna)

Maymetsi requires a doctor's prescription.

Krka, d.d., Novo mesto (Słowenia)

Maymetsi: ATC A10BD07. ATC is the WHO Anatomical Therapeutic Chemical classification.

50 mg + 850 mg, Tabletki powlekane

INN: Sitagliptinum + Metformini hydrochloridum

Data updated: 2026-04-13

ხელმისაწვდომია:

🇨🇿🇩🇪🇬🇧🇯🇵🇵🇱🇸🇰

ფორმა

Tabletki powlekane

დოზირება

50 mg + 850 mg

მიღების გზა

doustna

შენახვის პირობები

—

About This Product

Compare Maymetsiwith…

Used to treat:

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.